News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ardana Plc Announces Outcome of Pre-IND Meeting


1/9/2008 7:54:30 AM

Edinburgh, UK, January 9, 2008: Ardana Plc (LSE:ARA), the emerging pharmaceutical company specialising in improving human reproductive health, today announces the positive outcome of a pre-Investigational New Drug (IND) meeting with the United States Food and Drug Administration (FDA) for the development of its lead compound Teverelix LA (long-acting) for the treatment of endometriosis.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES